Ambrosino G, Varotto S, Basso S, Galavotti D, Cecchetto A, Carraro P, Naso A, De Silvestro G, Plebani M, Giron G, Abatangelo G, Donato D, Braga G P, Cestrone A, Marrelli L, Trombetta M, Lorenzelli V, Picardi A, Valente M L, Palu G, Colantoni A, Van Thiel D, Ricordi C, D'Amico D F
Department of Surgical and Gastroenterological Sciences, Section of General and Liver Transplant Surgery, University of Padova School of Medicine, Padova, Italy.
Int J Artif Organs. 2002 Oct;25(10):960-5. doi: 10.1177/039139880202501010.
Long-term maintenance of viability and expression of differentiated hepatocyte function is crucial for bioartificial liver support. We developed a new bioreactor design (ALEX), associated with a new extracellular autologous hepatocyte biomatrix (Porcine Autologous Biomatrix - PBM) support. To test this new bioreactor, we compared it to a standard BAL (BioArtificial Liver) cartridge in a ex vivo model using human plasma added to bilirubin, ammonium and lidocaine. A pathology study was performed on both bioreactors. The results suggest that ALEX allows a maximal contact between the perfusing plasma and the liver cells and a proper hepatocyte support by a cell-to-matrix attachment. ALEX is a suitable cell support bioreactor, guaranteeing long-term maintenance of the metabolic activity of hepatocytes when compared to a standard BAL cartridge.